Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Diabetes Stories

2014-02-25 08:31:50

Once-Weekly Dulaglutide Hits Primary Endpoint in Sixth Consecutive AWARD Trial INDIANAPOLIS, Feb. 25, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of the sixth AWARD (Assessment of Weekly AdministRation of LY2189265 in Diabetes) trial for once-weekly dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a treatment for type 2 diabetes. In the AWARD-6 study, once-weekly...

2014-02-24 23:04:11

Modifying Dietary Intake of Advanced Glycation Endproducts, or AGEs, Bolsters Body’s Defenses Against Alzheimer’s and Metabolic Syndrome, Say Mount Sinai Researchers New York, NY (PRWEB) February 24, 2014 Advanced glycation endproducts, or AGEs, are compounds commonly found in the so-called “Western diet,” and previously have been linked to increased body weight, diabetes, and possibly Alzheimer’s disease. Now, researchers at the Icahn School of Medicine at Mount Sinai have...

2014-02-24 12:27:34

BERKELY, Calif., Feb. 24, 2014 /PRNewswire/ -- NutritionQuest (http://www.nutritionquest.com), a health and wellness research company in Berkeley, CA has launched their latest online intervention program, which aims to change the course of patients with diagnosed pre-diabetes. The program, which features a highly individualized website, Android and iPhone apps, tailored emails, an interactive voice response coaching program, and tailored mailed newsletters, is the first of its kind to...

2014-02-24 08:28:05

Patient Recruitment and Enrollment Now Underway WOODCLIFF LAKE, N.J., Feb. 24, 2014 /PRNewswire/ -- Eisai Inc. today announced that patient recruitment and enrollment are currently underway for CAMELLIA-TIMI 61, a randomized double-blind, placebo-controlled outcomes trial to evaluate the effect of long-term treatment with lorcaserin HCl on the incidence of major adverse cardiovascular events and new onset type 2 diabetes mellitus in obese (BMI > 30 kg/m(2)) and overweight (BMI > 27...

2014-02-24 08:25:58

With API-integrated results, thousands of doctors using the free electronic health record (EHR) can now sync data from blood glucose meters, insulin pumps and electrocardiogram (ECG) recordings from mobile devices. SAN FRANCISCO, Feb. 24, 2014 /PRNewswire/ -- Practice Fusion, the country's largest physician-patient community, today announced a new integration between its free, web-based EHR solution and two cutting-edge medical device companies, AliveCor Inc. and Diasend. This...

2014-02-23 23:01:48

A new study says patients with diabetes are more likely to be readmitted to the hospital after bladder cancer surgery. Raleigh, NC (PRWEB) February 23, 2014 According to new research published in the Journal of Urology and reported by Cancer Monthly, diabetic patients do not typically recover as well after urological operations like bladder cancer surgery, and develop more complications, than do non-diabetic patients. The study evaluated the 30-day unplanned readmission rates of 7,795...

2014-02-22 23:01:14

Transparency Market Research Report added "Continuous Glucose Monitoring (CGM) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018" to its database. Browse full report: http://www.transparencymarketresearch.com/continuous-glucose-monitoring.html. Albany, New York, USA (PRWEB) February 22, 2014 Continuous glucose monitoring systems are real-time monitoring systems for checking glucose levels in the body. The system consists of a tiny sensor...

2014-02-22 23:01:07

Quoteslifeinsurance.com (http://quoteslifeinsurance.com/) announces a new blog, “ No Medical Exam Life Insurance Quotes For Diabetics!”. (PRWEB) February 22, 2014 Quoteslifeinsurance.com has released a blog explaining how to compare no medical exam life insurance quotes for diabetics. Diabetes will no longer disqualify people from getting life insurance. Life insurance plans that do not require medical examinations are a new product designed to be more accessible to people who have...

2014-02-22 23:01:04

The Firm is evaluating Byetta lawsuits on behalf of patients who allegedly developed pancreatic cancer, pancreatitis, or thyroid cancer due to their use of the Type 2 diabetes medication. New York, New York (PRWEB) February 22, 2014 A Byetta lawsuit (http://www.byettalawsuit.com) Plaintiff has withdrawn her motion seeking the consolidation of all federal claims involving allegations that the Type 2 diabetes drug caused patients to develop thyroid cancer, Bernstein Liebhard LLP reports....

2014-02-21 12:24:44

DUBLIN, Feb. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2n8qws/selfcare_medical ) has announced the addition of the "Concise Analysis of the International Self-Care Medical Devices Market - Forecast to 2019" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Self-care medical devices are used for measuring and monitoring various vital parameters of a patient. These devices play an important role in monitoring...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »